Macular Disease Foundation Australia
Macular disease funding bequest opens doors for blue sky thinking
A new stream of funding for ‘blue sky’ macular disease research is now available for early-career researchers after a woman ...
MDFA brings forward research grant applications date
The next round of Macular Disease Foundation Australia (MDFA) Research Grants has been brought forward, with the applications period opening ...
Aged care policies proving a major barrier for patients
Blanket policies in aged-care facilities, including complete lockdowns and two-week quarantines for residents who seek external medical treatment, have been ...
Tackling treatment adherence in AMD
As part of Macula Month this May, Insight explores why treatment adherence remains such a major challenge for some patients ...
Ita Buttrose fronts new eye injections TV campaign
Macular Disease Foundation Australia (MDFA) has launched a series of community service announcements featuring national icon Ms Ita Buttrose in ...
Patients gambling with vision due to COVID confusion
Uncertainty surrounding the COVID-19 lockdown measures has led to a major spike in missed appointments for macular disease treatment, sparking ...
Questions over economic viability of MBS proposals
Proposed cuts to the rebate and fee for intravitreal injections will impact bulk billing services and access to treatment, Australia’s ...
Novartis secures approval for AMD drug in Australia
Australia’s ophthalmic community has welcomed the approval of Novartis’ latest therapy for neovascular age-related macular degeneration (nAMD). Advocates hope the ...
MDFA releases $600,000 in new grants to tackle macular disease
The Macular Disease Foundation Australia (MDFA) has awarded $600,000 in new research grants to advance research into Indigenous diabetic vision ...